Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor

Prostate

Volumn 35, Issue 3, 1998, Pages 157-164

  Prahalada, S ^a   Rhodes, L ^a   Grossman, S J ^a   Heggan, D ^a   Keenan, K P ^a   Cukierski, M A ^a   Hoe, C M ^a   Berman, C ^a   Van Zwieten, M J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 reductase; Dihydrotestosterone; Finasteride; Histomorphology; Prostatic lobes; Rat; Testosterone

Indexed keywords

ANDROSTANOLONE; FINASTERIDE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; NONHUMAN; PH; PRIORITY JOURNAL; PROSTATE DISEASE; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; RADIOIMMUNOASSAY; RAT; SEXUAL MATURATION;

ANIMALS; CELL DIVISION; CHOLESTENONE 5 ALPHA-REDUCTASE; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; FINASTERIDE; MALE; OXIDOREDUCTASES; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

EID: 0032524975     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980515)35:3<157::AID-PROS1>3.0.CO;2-E     Document Type: Article

References (28)

1. Jesik CJ, Holland JM, Lee C: An anatomic and histologic study of the rat prostate. Prostate 1982;3:81-97.
2. Lee C, Holland JM: Anatomy, histology and ultrastructure (correlation with function), prostate, rat. In Jones TC, Mohr U, Hunt RD (eds): "Genital System: Monographs on Pathology of Laboratory Animals," New York: Springer-Verlag, 1987:239-251.
3. Price D: Comparative aspects of development and structure in the prostate. Monogr Natl Cancer Inst 1963;12:1-25.
4. Price D, Williams-Ashman HG: The accessory reproductive glands of mammals. In Young WC (ed): "Sex and Internal Secretions," Baltimore: Williams and Wilkins, 1961:366-448.
5. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y: The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8:338-362.
6. Fjosne HE, Haug E, Sunde A: Androgen metabolism in the different lobes of the prostate gland of intact, gonadectomized or hypophysectomized rats with or without androgen substitution. Scand J Clin Lab Invest 1994;54:83-93.
7. McNeal JE: Anatomy of the prostate: A historical survey of divergent views. Prostate 1980;1:3-13.
8. Bosland MC: Hyperplasia, adenoma, adenocarcinoma, prostate, rat. In Jones TC, Mohr U, Hunt RD (eds): "Genital System: Monographs on Pathology of Laboratory Animals," New York: Springer-Verlag, 1987:252-272.
9. Bosland MC: Animal models for the study of prostate carcinogenesis. J Cell Biochem [Suppl] 1992;16:89-98.
10. Isaacs JT: Development and Characteristics of the Available Animal Model Systems for the Study of Prostatic Cancer. In Coffey DS, Gardner WA Jr, Bruchovsky N, Resnick MI, Karr JP (eds): "Current Concepts and Approaches to the Study of Prostate Cancer." New York: Alan R. Liss, Inc., 1987:513-576.
11. Isaacs JT, Coffey DS: Animal model systems for the study of prostatic cancer. In Chisholm GD, Fair WR (eds): "Scientific Foundations of Urology," 3rd ed. Chicago, Yearbook, Inc., 1990, pp 613-620.
12. Leav I, Ho S-M, Ofner P, Merk FB, Kwan PW-L, Damassa D: Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988;80:1045-1053.
13. Azzolina B, Ellsworth KP, Andersson S, Geissler W, Bull H, Harris G: Inhibition of the rat 5α-reductase by finasteride: Evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol 1997;61:55-64.
14. Prahalada S, Peter CP, Keenan KP, Soper KA, Hertzog PR, van Zwieten MJ, Gordon LR, Bokelman DL: Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-α reductase inhibitor. Urology 1994;43:680-685.
15. Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK: The effect of finaste-ride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 1994;79:703-706.
16. Cukierski MA, Sina JL, Prahalada S, Wise LD, Antonello JM, MacDonald JS, Robertson RT: Decreased fertility in male rats administered the 5α-reductase inhibitor, finasteride, is due to deficits in copulatory plug formation. Reprod Toxicol 1991;5: 353-362.
17. Wilk MB, Shapiro SS: The joint assessment of normality of several independent samples. Technometrics 1968;10:825-839.
18. Snedecor GW, Cochran WG: Levene's test for variance homogeneity. In "Statistical Methods," 8th ed. Iowa State University Press, 1989:252-253.
19. Tukey JW, Ciminera JL, Heyse JF: Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985;41:295-301.
20. Snedecor GW, Cochran WG: Two-sampled t-test. In: "Statistical Methods," 8th ed. Iowa State University Press, 1989:83-93.
21. Harter HL: Expected values of normal order statistics. Biometrika 1961;48:151-165.
22. Normington K, Russel DW: Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes. J Biol Chem 1992;267:19548-19554.
23. Rittmaster RS, Mager KE, Manning AP, Norman RW, Lazier CB: Differential effect of 5α-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Mol Endocrinol 1991;5:1023-1029.
24. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G: Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5α-reductase inhibitor finasteride. Endocrinology 1995;136:741-748.
25. Shao TC, Kong A, Marafelia P, Cunningham GR: Effects of finasteride on the rat ventral prostate. J Androl 1993;14:79-86.
26. Tsukamoto S, Akaza H, Imada S, Koiso K, Shirai T, Ideyama Y, Kudo M: Chemoprevention of rat prostate carcinogenesis by use of finasteride or Casodex. J Natl Cancer Inst 1995;87:842-843.
27. Ito N, Shirai T, Masui T, Ogewa K, Kato T, Takahaski S: Mechanistic analysis of multistage carcinogenesis in the rat prostate. In Harris CC, Hirohashi S, Ito N, Pitot HC, Sugimura T, Terada M, Yokota J (eds): "Multistage Carcinogenesis," Tokyo: Japan Scientific Societies Press, 1992:125-133.
28. Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J: Influence of diethylstilbestrol, leuprorelin (a luteinizing hormone-releasing hormone analog), finasteride (a 5-alpha reductase inhibitor), and castration on the lobar subdivisions of the rat prostate. Prostate 1996;29:1-14.